The University of Southern California and the Brookings Institution categorized the main policy issues for lawmakers writing drug pricing legislation, including whether the government or an outside group should negotiate prices, which drugs to target, who gets those prices, how to assess value and what to do when negotiations fail. Democrats plan to direct Medicare to negotiate drug prices in their budget reconciliation bill, and the Brookings analysis is meant to help conceptualize the big questions facing lawmakers. What happens...